Alpha-1 Antitrypsin Deficiency: Symptoms, Diagnosis, and Treatment Options

Alpha-1 antitrypsin deficiency (AATD) is a rare inherited condition that can affect the lungs and liver. It occurs when the body does not produce enough alpha-1 antitrypsin (AAT), a protein that helps protect the lungs from damage caused by inflammation. Without adequate levels of this protein, individuals may have an increased risk of developing chronic lung disease and, in some cases, liver disease. Early diagnosis and appropriate management can help reduce complications and improve quality of life.

What Is Alpha-1 Antitrypsin Deficiency?

AATD is caused by changes in the SERPINA1 gene, which affect the production or function of the alpha-1 antitrypsin protein.

The condition primarily affects:

• The lungs
• The liver

Because it is inherited, AATD can run in families.

Common Symptoms

Symptoms vary from person to person and may not appear until adulthood.

Lung-related symptoms may include:

• Shortness of breath
• Wheezing
• Chronic cough
• Frequent respiratory infections
• Reduced exercise tolerance

Liver-related symptoms may include:

• Fatigue
• Yellowing of the skin or eyes (jaundice)
• Swelling of the abdomen
• Elevated liver enzymes
• Signs of chronic liver disease

Some people have few or no symptoms for many years.

Risk Factors

Factors that may increase the likelihood of complications include:

• Inheriting abnormal AAT genes from both parents
• Smoking
• Exposure to dust, fumes, or air pollution
• Recurrent respiratory infections
• Family history of AATD

Avoiding tobacco smoke is one of the most important steps for protecting lung health.

How It Is Diagnosed

Diagnosis may involve:

• Blood tests to measure alpha-1 antitrypsin levels
• Genetic testing
• Pulmonary function tests
• Liver function tests
• Chest imaging, such as a CT scan
• Evaluation of family history

Early diagnosis allows treatment to begin before significant organ damage occurs.

Treatment Options

Treatment depends on the organs affected and the severity of the condition.

Management may include:

• Bronchodilator medications for airflow obstruction
• Inhaled therapies when appropriate
• Pulmonary rehabilitation
• Vaccinations to reduce the risk of respiratory infections
• Oxygen therapy for advanced lung disease
• Augmentation therapy for eligible individuals with lung involvement
• Liver disease management when needed

Treatment plans are individualized based on each person's health status.

Lifestyle Measures

Healthy habits can help protect lung and liver function.

Recommendations often include:

• Avoiding smoking and secondhand smoke
• Staying physically active as tolerated
• Eating a balanced diet
• Receiving recommended vaccinations
• Reducing exposure to workplace dust and chemical fumes
• Limiting alcohol intake, especially when liver disease is present

These measures complement medical treatment.

Monitoring

Regular follow-up appointments may include:

• Lung function testing
• Liver function monitoring
• Imaging studies when appropriate
• Review of symptoms
• Assessment of treatment effectiveness

Routine monitoring helps detect changes early.

When to Seek Medical Attention

Prompt medical evaluation is recommended if there is:

• Increasing shortness of breath
• Persistent cough with worsening symptoms
• Fever or signs of a lung infection
• Jaundice
• Swelling of the legs or abdomen
• Unexplained fatigue or weight loss

Early treatment of complications may improve outcomes.

Conclusion

Alpha-1 antitrypsin deficiency is a rare inherited disorder that can affect both the lungs and liver. Early diagnosis through blood tests and genetic testing, combined with appropriate medical treatment, healthy lifestyle choices, and regular monitoring, can help slow disease progression and improve long-term health. Individuals with a family history of AATD or unexplained lung or liver disease should discuss evaluation with a healthcare professional.